Medicare Enrolled

Dr. Lisa Thomas, MD

Hematology & Oncology · Dunmore, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1100 MEADE ST, Dunmore, PA 18512
5703423675
Registered in NPPES since 2005
NPI: 1346239894 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Thomas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thomas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Thomas

Dr. Lisa Thomas is a hematology & oncology specialist in Dunmore, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Thomas performed 108,793 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Thomas received a total of $6,906 from 32 pharmaceutical and/or device companies across 62 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Thomas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 5% volume in PA $6,906 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
108,793
Medicare services
Top 5% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
50,490 $0 $5
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
11,600 $6 $27
Iron infusion (Monoferric) 6,200 $16 $40
Paclitaxel chemotherapy injection 6,111 $0 $15
Denosumab injection (Prolia/Xgeva) 5,760 $18 $30
Epoetin alfa injection (Retacrit) for anemia
An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units.
3,120 $6 $20
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
3,083 $0 $10
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
2,740 $36 $125
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
2,700 $8 $30
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
2,486 $10 $35
Injection, fulvestrant, 25 mg 1,240 $8 $180
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,108 $88 $140
Injection, granisetron hydrochloride, 100 mcg 1,000 $0 $189
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
868 $127 $190
Pegfilgrastim injection, 0.5 mg
An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions.
792 $76 $500
Anti-nausea injection (Aloxi/palonosetron) 760 $1 $60
Iron level test 743 $6 $25
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
743 $9 $35
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
741 $13 $40
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
664 $10 $40
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
408 $21 $100
Cyclophosphamide, 100 mg 390 $16 $100
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
372 $2 $10
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
345 $95 $250
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 310 $20 $75
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
245 $47 $150
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
245 $21 $85
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
230 $53 $100
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
225 $11 $50
Injection, potassium chloride, per 2 meq 210 $0 $5
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
206 $1 $9
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
198 $2 $215
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
179 $48 $110
Manual white blood cell count
A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present.
177 $4 $20
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
177 $6 $15
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
169 $6 $400
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
162 $15 $75
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
133 $24 $80
Carcinoembryonic antigen (CEA) level test
A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer.
129 $18 $47
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
103 $1 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
91 $59 $105
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
88 $15 $55
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
75 $15 $50
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
70 $1 $5
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
66 $4 $15
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
65 $8 $50
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
63 $41 $150
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
58 $16 $40
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 48 $326 $1,500
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
47 $7 $17
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
47 $27 $100
On-body injector for subcutaneous injection
A device is applied to the skin to automatically deliver a medication injection under the skin.
47 $14 $40
Immunologic analysis for detection of tumor antigen, quantitative; ca 125 46 $20 $75
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
43 $1 $10
PSA test (prostate cancer screening) 40 $18 $75
New patient office visit, complex (60-74 min) 40 $158 $293
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
40 $2 $15
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
37 $24 $150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
34 $117 $243
Prolonged intravenous chemotherapy administration
This procedure involves the administration of chemotherapy medication directly into a vein over an extended period.
33 $95 $285
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
31 $133 $238
PSA test (prostate cancer screening)
A blood test that measures the level of prostate-specific antigen to screen for prostate cancer.
22 $19 $75
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
20 $6 $20
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
18 $64 $125
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
16 $72 $100
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
16 $29 $50
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
15 $132 $500
Phosphate level test
A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong.
15 $5 $14
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
55.8% high complexity
33.7% medium
10.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,906
Total received (2018-2024)
Avg $987/year across 7 years
Top 27% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
62
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,445
2023
$277
2022
$35
2021
$352
2020
$15
2019
$2,297
2018
$486

Payments by company (2024)

Incyte Corporation
$2,580
AstraZeneca Pharmaceuticals LP
$533
Exelixis Inc.
$100
Lilly USA, LLC
$79
SOBI, INC
$75
GlaxoSmithKline, LLC.
$23
Merck Sharp & Dohme LLC
$22
ABBVIE INC.
$18
Astellas Pharma US Inc
$15
Top 3 companies account for 93.3% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$2,593
Seattle Genetics, Inc.
$1,705
AstraZeneca Pharmaceuticals LP
$551
Varian Medical Systems, Inc.
$480
Janssen Scientific Affairs, LLC
$340
Astellas Pharma US Inc
$236
Exelixis Inc.
$111
E.R. Squibb & Sons, L.L.C.
$107
Novartis Pharmaceuticals Corporation
$102
Lilly USA, LLC
$79
SOBI, INC
$75
Bayer HealthCare Pharmaceuticals Inc.
$65
GENZYME CORPORATION
$57
GlaxoSmithKline, LLC.
$42
Pharmacyclics LLC, An AbbVie Company
$42
Janssen Biotech, Inc.
$41
Genentech USA, Inc.
$31
Merck Sharp & Dohme Corporation
$25
Merck Sharp & Dohme LLC
$22
Daiichi Sankyo Inc.
$20
ABBVIE INC.
$18
Celgene Corporation
$17
Amgen Inc.
$17
AbbVie, Inc.
$16
Spectrum Pharmaceuticals Inc.
$16
Regeneron Healthcare Solutions, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$16
PFIZER INC.
$15
JAZZ PHARMACEUTICALS INC.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$12
Ferring Pharmaceuticals Inc.
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 70.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Abraxane · Cabometyx · DARZALEX · DOPTELET · ELITEK · ENHERTU · EPKINLY · ERLEADA · INJECTAFER · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · Kyprolis · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LYNPARZA · MEKINIST · NINLARO · NOCDURNA · OJJAARA · OPDIVO · Perjeta · SOMATULINE DEPOT · Stivarga · TAGRISSO · TASIGNA · VYXEOS · Venclexta · XALKORI · XTANDI · Xofigo · Xtandi · Zevalin
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Dunmore?
Compare hematology & oncology specialists in the Dunmore area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
15
County median income
$64,691
Nearest hospital to ZIP centroid (approximate)
GEISINGER-COMMUNITY MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Thomas is a mixed practice specialist, with above-average Medicare volume (top 5% in PA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Thomas experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Thomas performed 50,490 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Thomas receive payments from pharmaceutical companies?
Yes. Dr. Thomas received a total of $6,906 from 32 companies across 62 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thomas's costs compare to other hematology & oncology specialists in Dunmore?
Dr. Thomas's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thomas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →